Green Tea for Uterine Fibroid | ClinicSearch (2025)

Uterine leiomyoma is major health issue for women as they affect the quality of life. Every gynecologist will agree that it is a dilemma one faces each day related to counseling of patients for uterine fibroid treatment as majority of them asymptomatic and those that are symptomatic presenting with abnormal bleeding, pain and occasional infertility need medical or surgical treatment with medical options not fully backed by scientific research1. It becomes all the more difficult in deciding the treatment plan if the woman id desirous of child birth or want to preserve fertility. The fibroids can be subserosal, intramural and intramucosal with the intramucosal presenting with symptoms.

The current management options span from expectant observation to surgical options like hysterectomy, myomectomy uterine artery embolization and image guided focused ultrasound thermal therapy2. The offering of surgical options in asymptomatic individuals is treacherous and brings into limelight medical alternatives that unfortunately not approved like in other diseases where they are mainstay of treatment. The literature studies have elaborated on the use of depot medroxy progesterone acetate (DMPA) (Lumbiganon et al3 and Venkatachalam et al4), progestin releasing intrauterine system (LNG-IUS) (Sayed et al5), combined oral contraceptive pills (Qin et al6), 25 (OH) vitamin D (Sabry et al and Haider et al7). We briefly summarize the role of green tea extract –Epigallocatechin gallate (EGCG) as a potential treatment option for uterine fibroids based on available literature studies8-10.

What is green tea

Green tea is a type of tea made from Camellia Sinensis leaves and buds that are not subjected to withering and oxidation process that is routinely used to make Oolong teas and black teas. The origin of green tea is from China. The constituents of green tea are shown in table-1.

Green tea health benefits

The flavonoids have no biological proven role in human body. EGCG has been of major interest of various scientific researches. The health benefits of green tea consumption are highly debatable and controversial. The scientific panel in 2011 under European commission [11] rejected any claims of health benefit from green tea although it was accepted that green tea enhances mental alertness due to caffeine content. The other health effects lacked backing from scientific data.

In a review from Cochrane collaboration12 in 2020, side effects of green tea like gastrointestinal disorders, deranged liver enzymes, raised blood pressure; skin reactions and insomnia were mentioned. Green tea has taken the beverage market by surprise as it is easy to prepare, devoid of milk, instant preparation particularly at work place and taste.

Green tea & fibroids

Oral EGCG consumption was used in a randomized control trial by Chow et al [13] who in their study used it in doses of 400,800 or 1200 mg per day and reported mild nausea as the side effect in 3% of the test subjects. The study emphasized on safety profile of EGCG. In another study by Luo et al [14] it was found that there was decrease in oxidative biomarkers by green tea use. There are two landmark studies in literature by Roshydy et al [15] and Zhang et al [16]. Which have reported statistically significant reduction in the size of uterine fibroids verses placebo.

Roshydy et al 15recruited 39 subjects aged 18-50 years with day 3 follicular stimulating hormone <10mIU>

In absence of FDA approved medical treatment for fibroids the search for effective treatment goes on. The currently used hormonal treatments are met with adverse effects like loss of bone density, endometrial hyperplasia and dysplasia [17, 18].

The reduced size of fibroid may be attributed to inhibitory effect on proliferating leiomyoma tumor cells and apoptosis [16].

In terms of safety there are literature studies by Shen et al 19, Matsuyama et al 20, Pisters et al 21 and others 22 where green tea extract was well tolerated with no hepatotoxicity. It was caffeine that was dose limiting factor and eliminating caffeine in green tea could ameliorate many of the side effects23.

Green tea could be effective alternative with potential therapeutic role for uterine fibroid management although there are limited studies in literature till date but it is an opportunity for researchers in India and South Asia having strong alternative medicine backbone to conduct studies and trials for more scientific backing. Green tea could serve as a game changer if the trials prove its clinical efficacy with its role as an antioxidant been slowly recognized it is quite possible that it is used as medical treatment in near future for fibroids.

1. E. A. Stewart, “Uterine fibroids,” Lancet, vol. 357, no. 9252, pp. 293–298, 2001.
   View at Publisher | View at Google Scholar
2. E.-E. R. Othman and A. Al-Hendy, “Molecular genetics and racial disparities of uterine leiomyomas,” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 22, no. 4, pp. 589–601, 2008.
   View at Publisher | View at Google Scholar
3. Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y.Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study.Br J Obstet Gynaecol1996; 103:909–914.
   View at Publisher | View at Google Scholar
4. S Venkatachalam, JS Bagratee & J Moodley(2004)Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study,Journal of Obstetrics and Gynaecology,24:7,798-800.
   View at Publisher | View at Google Scholar
5. Sayed GH, Zakherah MS, El-Nashar SA, Shaaban MM. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.Int J Gynaecol Obstet. 2011; 112(2):126-130.
   View at Publisher | View at Google Scholar
6. Qin J, Yang T, Kong F et al. Oral contraceptive use and uterine leiomyoma risk: a meta-analysis based on cohort and case–control studies. Arch. Gynecol. Obs. 288(1), 139-148 (2013).
   View at Publisher | View at Google Scholar
7. Sabry M, Halder SK, Allah AS, Roshdy E, Rajaratnam V, Al-Hendy A. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study.Int. J. Womens Health.2013; 5:93–100
   View at Publisher | View at Google Scholar
8. J. E. Chung, M. Kurisawa, Y. J. Kim, H. Uyama, and S. Kobayashi, “Amplification of antioxidant activity of catechin by polycondensation with acetaldehyde,” Biomacromolecules, vol. 5, no. 1, pp. 113–118, 2004.
   View at Publisher | View at Google Scholar
9. J. K. Lin, Y. C. Liang, and S. Y. Lin-Shiau, “Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade,” Biochemical Pharmacology, vol. 58, no. 6, pp. 911–915, 1999.
   View at Publisher | View at Google Scholar
10. N. Khan, F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar, “Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate,” Cancer Research, vol. 66, no. 5, pp. 2500–2505, 2006.
    View at Publisher | View at Google Scholar
11. EFSA ANS Panel(EFSA Panelon Food Additives and Nutrient Sources added to Food),Younes et al 2018.Scientific Opinion on the safety of green tea catechins.EFSA Journal2018;16(4):5239, 89 pp.
    View at Publisher | View at Google Scholar
12. Ahmed R.S., Liu G., Renzetti A., Farshi P., Yang H., Soave C., Saed G., El-Ghoneimy A.A., El-Banna H.A., Foldes R., et al. Biological and mechanistic characterization of novel prodrugs of green tea polyphenol epigallocatechin gallate analogs in human leiomyoma cell lines.J. Cell. Biochem.2016; 117:2357–2369.
    View at Publisher | View at Google Scholar
13. Chow HH, Hakim IA, Vining DR, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals.Clin Cancer Res.2005; 11:4627–4633.
    View at Publisher | View at Google Scholar
14. Luo H, Tang L, Tang M, et al. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8- hydroxydeoxyguanosine.Carcinogenesis.2006; 27:262–268.
    View at Publisher | View at Google Scholar
15. Roshdy E., Rajaratnam V., Maitra S., Sabry M., Allah A.S., Al-Hendy A. Treatment of symptomatic uterine fibroids with green tea extract: A pilot randomized controlled clinical study.Int. J. Womens Health.2013; 5:477–486.
    View at Publisher | View at Google Scholar
16. Zhang D., Al-Hendy M., Richard-Davis G., Montgomery-Rice V., Sharan C., Rajaratnam V., Khurana A., Al-Hendy A. Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice.Am. J. Obstet. Gynecol.2010; 202:289. e1–289.e9.
    View at Publisher | View at Google Scholar
17. Matsuzaki S., Darcha C. Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.Hum. Reprod.2014; 29:1677–1687.
    View at Publisher | View at Google Scholar
18. Donnez J, Tatarchuk TF, Bouchard P, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery.N Engl J Med.2012; 366:409–420.
    View at Publisher | View at Google Scholar
19. Shen CL, Chyu MC, Pence BC, Yeh JK, Zhang Y, Felton CK. Green tea polyphenols supplementation and tai chi exercise for postmenopausal osteopenic women: safety and quality of life report.BMC Complement Altern Med.2010; 10:76.
    View at Publisher | View at Google Scholar
20. Matsuyama T, Tanaka Y, Kamimaki I, Nagao T, Taokimitsu I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children.Obesity (Silver Spring)2008; 16:1338–1348.
    View at Publisher | View at Google Scholar
21. Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK. Phase I trial of oral green tea extract in adult patients with solid tumors.J Clin Oncol.2001; 19:1830–1838.
    View at Publisher | View at Google Scholar
22. Fiorini RN, Donovan JL, Rodwell D, et al. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.Liver Transpl.2005; 11:298–30.
    View at Publisher | View at Google Scholar
23. Nishikawa T, Nakajimi T, Moriguchi M, et al. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.J Hepatol.2006; 44:1074–1082.
    View at Publisher | View at Google Scholar